Neuphoria Therapeutics Inc. Proceeds from Issuance of Warrants
Neuphoria Therapeutics Inc. (NEUP) reported Proceeds from Issuance of Warrants of $5.00 million for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2025-09-29
- Neuphoria Therapeutics Inc. proceeds from issuance of warrants for fiscal 2024 was $5.00M.
| Period end | Proceeds from Issuance of Warrants 12 month |
|---|---|
| 2024-06-30 | $5.00M 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |